Explanation
Adepottypicatantipsychotic
Patientsaretypically offered oraL atypicau anti-psychotics(amisulpride. olanzapine,quetiapine.risperidone and
zotepinej. whichareqenerallyused asfrst-tinetreatmentforapatientwith schizophrenia.Howeverfthevfait
tocomotywiththis.suchasinthiscase.thendepotmedication(eithertvpicauoratypicau could beconsidered.
Theobviousbeneftofdepotmedicationisthattisadministeredatreqularintervals(aeneraly 2-4-weeky bv
medicaustaff.Therefore,thepatiemtdoesnothavetoremembertotaketonadaitbasis.Staff alsoknowthat
thepatient hasdefinitety been receivingtheir medication.Thedrawbacksof depotmedication arethe
discomfortoftheiniectionandproblemswiththeinjection sitee.g.infection or abscessformation
@1MINENDOCRINE
